Showing 1 - 12 results of 12 for search 'Dhaval K. Shah', query time: 0.06s Refine Results
  1. 1
    Development and validation of an LC-MS/MS method for tyrphostin A9

    Development and validation of an LC-MS/MS method for tyrphostin A9 by Lyndsey F. Meyer, Dhaval K. Shah

    Published 2019-06-01
    Get full text
    Article
  2. 2
    Pulmonary Pharmacokinetics of Antibody and Antibody Fragments Following Systemic and Local Administration in Mice

    Pulmonary Pharmacokinetics of Antibody and Antibody Fragments Following Systemic and Local Administration in Mice by Prabhas Jagdale, Ashwni Verma, Dhaval K. Shah

    Published 2024-09-01
    Get full text
    Article
  3. 3
    Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy

    Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy by Johannes Schropp, Antari Khot, Dhaval K. Shah, Gilbert Koch

    Published 2019-03-01
    Get full text
    Article
  4. 4
    Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes

    Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes by Hsuan-Ping Chang, Huyen Khanh Le, Dhaval K. Shah

    Published 2023-04-01
    Get full text
    Article
  5. 5
    Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in human

    Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in human by Dimitris G. Patsatzis, Shengjia Wu, Dhaval K. Shah, Dimitris A. Goussis

    Published 2022-04-01
    Get full text
    Article
  6. 6
    Effect of variable domain charge on in vitro and in vivo disposition of monoclonal antibodies

    Effect of variable domain charge on in vitro and in vivo disposition of monoclonal antibodies by Shufang Liu, Ashwni Verma, Hubert Kettenberger, Wolfgang F. Richter, Dhaval K. Shah

    Published 2021-01-01
    Get full text
    Article
  7. 7
    A Cell-Level Systems PK-PD Model to Characterize In Vivo Efficacy of ADCs

    A Cell-Level Systems PK-PD Model to Characterize In Vivo Efficacy of ADCs by Aman P. Singh, Leiming Guo, Ashwni Verma, Gloria Gao-Li Wong, Dhaval K. Shah

    Published 2019-02-01
    Get full text
    Article
  8. 8
    Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling

    Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling by Mokshada Kumar, Sravani Lanke, Alka Yadav, Mfonabasi Ette, Donald E. Mager, Dhaval K. Shah

    Published 2024-07-01
    Get full text
    Article
  9. 9
    Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis

    Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis by Hsueh-Yuan Chang, Shengjia Wu, Yingyi Li, Wanying Zhang, Matthew Burrell, Carl I. Webster, Dhaval K. Shah

    Published 2021-01-01
    Get full text
    Article
  10. 10
    Heparan sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE

    Heparan sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE by Miaomiao Li, Chih Yean Ong, Christophe J Langouët-Astrié, Lisi Tan, Ashwni Verma, Yimu Yang, Xiaoxiao Zhang, Dhaval K Shah, Eric P Schmidt, Ding Xu

    Published 2022-02-01
    Get full text
    Article
  11. 11
    Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example

    Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example by Marc C. Huisman, C. Willemien Menke-van der Houven van Oordt, Josée M. Zijlstra, Otto S. Hoekstra, Ronald Boellaard, Guus A. M. S. van Dongen, Dhaval K. Shah, Yvonne W. S. Jauw

    Published 2021-08-01
    Get full text
    Article
  12. 12
    SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases

    SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases by Abdelsattar M. Omar, Abdelsattar M. Omar, Abdelsattar M. Omar, Maan T. Khayat, Farid Ahmed, Farid Ahmed, Yosra A. Muhammad, Azizah M. Malebari, Sara M. Ibrahim, Mohammad I. Khan, Mohammad I. Khan, Dhaval K. Shah, Wayne E. Childers, Moustafa E. El-Araby, Moustafa E. El-Araby

    Published 2022-05-01
    Get full text
    Article

Search Tools: